Đorđe Popović
Associate Professor
Clinical Center of Vojvodina, Clinic for Endocrinology, Diabetes and Metabolic Disorders
djordje.popovic@mf.uns.ac.rs
Phone: 0214843509
ORCID ID : 0000-0002-2763-1326
Clinical Center of Vojvodina, Clinic for Endocrinology, Diabetes and Metabolic Disorders
djordje.popovic@mf.uns.ac.rs
Phone: 0214843509
ORCID ID : 0000-0002-2763-1326
| Academic career | Year | Institution | Field |
|---|---|---|---|
Status Acquired |
2023 |
Faculty of Medicine Novi Sad |
Internal Medicine (Endocrinology and Metabolic Diseases) | Subspecialization |
2019 |
Faculty of Medicine Novi Sad |
Endocrinology |
Specialization |
2017 |
Faculty of Medicine Novi Sad |
Internal Medicine |
PhD |
2016 |
Faculty of Medicine Novi Sad |
Clinical Medicine |
Graduated |
2008 |
Faculty of Medicine Novi Sad |
General Medicine |
| M | Description |
|---|---|
21 | Popovic DS, Stokic E, Popovic SL. GLP-1 receptor agonists and type 1 diabetes-where do we stand? Curr Pharm Des 2015; 21:5292-5298. |
25 | Popovic DS, Stokic E, Tomic-Naglic D, Novakovic-Paro J, Mitrovic M, Vukovic B, Kovacev-Zavisic B. Circulating sclerostin levels and cardiovascular risk in obesity. Int J Cardiol 2016; 214:48-50. |
25 | Popovic DS, Tomic-Naglic D, Stokic E. Relation of resistin, leptin and adiponectin-trinity of adipose tissue dysfunction assessment. Eur J Inter Med 2014; 25:e80-e81. |
23 | Popovic DS, Papanas N. Double diabetes: a growing problem requiring solutions. Exp Clin Endocrinol Diabetes 2022; 130:268-274. |
25 | Popovic DS, Del Prato S. 1h post-load blood glucose for detection of individuals at increased risk of diabetes and cardiovascular disease. Diabetes Res Clin Pract 2016; 120:184-185. |
22 | Popovic DS, Rizzo M, Stokic E, Papanas N. New sub-phenotyping of subjects at high risk of type 2 diabetes: what are the potential clinical implications? Diabetes Ther 2021; 12:1605-1611. |
22 | Popovic DS, Mitrovic M, Tomic-Naglic D, Icin T, Bajkin I, Vukovic B, Benc D, Zivanovic Z, Kovacev-Zavisic B, Stokic E. The Wnt/β-catenin signalling pathway inhibitor sclerostin is a biomarker for early atherosclerosis in obesity. Curr Neurovasc Res 2017; 14:200-206. |
22 | Popovic DS, Stokic E, Mitrovic M, Tomic-Naglic D, Pejin R, Icin T, Vukovic B, Zivanovic Z, Pejakovic S, Kovacev-Zavisic B. Surrogates of insulin sensitivity and indices of cardiometabolic profile in obesity. Curr Vasc Pharmacol 2017; 15:380-389. |
23 | Popovic DS, Tomic-Naglic D, Mitrovic M, Zivanovic Z, Vukovic B, Stokic E. 1h post-load blood glucose in the identification of proatherogenic cardiometabolic profile in obesity. Endocr Metab Immune Disord Drug Targets 2017; 17:226-237. |
22 | Popovic DS, Papanas N, Pantea Stoian A, Rizvi AA, Janez A, Rizzo M. Use of novel antidiabetic agents in patients with type 2 diabetes and COVID-19: a critical review. Diabetes Ther 2021; 12:3037-3054. |
| Course | Studies |
|---|---|
Introduction to Clinical Practice II | Integrated Academic Studies in Medicine |
Clinical Propedeutics | Integrated Academic Studies in Medicine |
Internal Medicine | Integrated Academic Studies in Medicine |
Internal Medicine | Integrated Academic Studies in Dentistry |
Clinical Propedeutics | Undergraduate academic studies in nursing |
Nursing Care of Internist Patients with Internal Medicine | Undergraduate academic studies in nursing |
Clinical Propedeutics | Undergraduate applied studies in nursing |
Nursing Care of Internist Patients with Internal Medicine | Undergraduate applied studies in nursing |
Internal Medicine | Undergraduate Academic Studies in Medical Rehabilitation |